Biogen reported $34.23B in Market Capitalization this January of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 190.63B 8.32B
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Acorda Therapeutics ACOR:US $ 0.05B 0.01B
Alexion Pharmaceuticals ALXN:US $ 33.78B 0.39B
ALKERMES ALKS:US 4.98B 1.04B
Amgen AMGN:US $ 120.75B 19.29B
Bayer BAYN:GR 46.18B 4.3B
Biogen BIIB:US $ 42.18B 9.96B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 0.87B
Bristol Myers Squibb BMY:US $ 131.34B 17.15B
Eli Lilly And LLY:US $ 221.02B 0.9B
Esperion Therapeutics ESPR:US $ 0.34B 0.26B
Gilead Sciences GILD:US $ 87.58B 1.22B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Intercept Pharmaceuticals ICPT:US $ 0.49B 0.17B
Intra Cellular Therapies ITCI:US $ 3.03B 0.29B
Marinus Pharmaceuticals MRNS:US $ 0.42B 0.24B
Merk MRK:US $ 190.13B 6.79B
Moderna Inc MRNA:US $ 155.35B 61B
Neurocrine Biosciences NBIX:US $ 9.08B 0.12B
Novartis NOVN:VX 187.04B 20.99B
Pfizer PFE:US $ 241.14B 21.94B
Ptc Therapeutics PTCT:US $ 2.63B 0.36B
Puma Biotechnology PBYI:US $ 0.29B 0.08B
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Sangamo Biosciences SGMO:US $ 1.31B 0.41B
Sanofi SNY:US 121.56B 10.5B
Sanofi SAN:FP 104.97B 6.43B
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Teva Pharmaceutical TEVA:IT 34.99B 801.25M
Ultragenyx Pharmaceutical RARE:US $ 6.12B 0.32B
United Therapeutics UTHR:US $ 8.29B 0.25B
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
YTE INCY:US $ 15.19B 3.31B